Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, MN, USA.
EuroIntervention. 2020 Feb 20;15(14):1262-1268. doi: 10.4244/EIJ-D-18-00920.
Myocardial bridging (MB), characterised by the epicardial coronary vessel diving into the myocardium, is present in up to one third of adults and is associated with angina and acute coronary syndromes. MB is accompanied by altered blood flow mechanics and regional changes in wall sheer stress. The purpose of this study was to determine the association between myocardial bridging and coronary endothelial dysfunction.
Patients presenting with chest pain and found to have non-obstructive CAD (stenosis <40%) on angiography underwent an invasive assessment of epicardial and microvascular endothelial function. Epicardial endothelial function was assessed by measuring the percent change in coronary artery diameter in response to intracoronary infusions of acetylcholine (%ΔCADAch). Epicardial endothelial dysfunction was defined as a %ΔCADAch of <-20%. Microvascular endothelial function was assessed by the percent change in coronary blood flow in response to intracoronary infusions of acetylcholine (%ΔCBFAch), and microvascular endothelial dysfunction was defined as a %ΔCBFAch of <50%. MB was diagnosed angiographically by identifying the characteristic reduction in minimal luminal diameter during systole. Patients were divided into those with and those without MB, and the frequency of epicardial endothelial dysfunction and microvascular endothelial dysfunction was compared between patients with versus those without MB. Between 1993 and 2012, 1,469 patients (mean age 50.4 years, 35% male) underwent coronary angiography and invasive testing of endothelial function. Two hundred and eight (14.2%) patients were found to have MB in the LAD. Patients with any MB had a significantly higher frequency of endothelial dysfunction within the mid and/or distal vessel segment compared to patients without MB (60.1% vs 50.4%, p=0.012). In multivariate analyses, mid and/or distal vessel MB was a significant predictor of mid and/or distal vessel epicardial endothelial dysfunction (OR 1.44, 95% CI: 1.04-2.00, p=0.029) and of microvascular endothelial dysfunction (OR 1.34, 95% CI: 1.00-1.82, p=0.050).
MB co-localises with epicardial endothelial dysfunction and is significantly associated with microvascular endothelial dysfunction in symptomatic patients with non-obstructive CAD, supporting its potential role as a mechanism for angina in symptomatic patients with MB.
心肌桥(MB)的特征是心外膜冠状动脉潜入心肌,在多达三分之一的成年人中存在,并与心绞痛和急性冠状动脉综合征有关。MB 伴有血流动力学改变和壁切应力的区域性变化。本研究的目的是确定心肌桥与冠状动脉内皮功能障碍之间的关系。
因胸痛就诊且血管造影显示非阻塞性 CAD(狭窄 <40%)的患者接受了心外膜和微血管内皮功能的侵袭性评估。通过测量乙酰胆碱(%ΔCADAch)冠状动脉内输注引起的冠状动脉直径变化百分比来评估心外膜内皮功能。心外膜内皮功能障碍定义为 %ΔCADAch 小于-20%。通过冠状动脉内输注乙酰胆碱(%ΔCBFAch)引起的冠状动脉血流变化百分比评估微血管内皮功能,微血管内皮功能障碍定义为 %ΔCBFAch <50%。通过识别收缩期最小管腔直径的特征性减小,在血管造影中诊断 MB。患者分为有 MB 和无 MB 两组,比较有 MB 和无 MB 患者之间心外膜内皮功能障碍和微血管内皮功能障碍的发生率。1993 年至 2012 年,1469 例患者(平均年龄 50.4 岁,35%为男性)接受了冠状动脉造影和内皮功能的侵袭性检查。208 例(14.2%)患者在 LAD 中发现 MB。与无 MB 的患者相比,任何 MB 的患者在中段和/或远段血管段的内皮功能障碍发生率明显更高(60.1%比 50.4%,p=0.012)。多变量分析显示,中段和/或远段血管 MB 是中段和/或远段血管心外膜内皮功能障碍(OR 1.44,95%CI:1.04-2.00,p=0.029)和微血管内皮功能障碍(OR 1.34,95%CI:1.00-1.82,p=0.050)的显著预测因子。
MB 与心外膜内皮功能障碍共存,并与有症状的非阻塞性 CAD 患者的微血管内皮功能障碍显著相关,支持其在有症状的 MB 患者中作为心绞痛机制的潜在作用。